Whitehawk Therapeutics (WHWK) Total Current Liabilities (2018 - 2025)
Historic Total Current Liabilities for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $9.8 million.
- Whitehawk Therapeutics' Total Current Liabilities fell 3771.58% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 3771.58%. This contributed to the annual value of $17.1 million for FY2024, which is 3531.35% down from last year.
- Whitehawk Therapeutics' Total Current Liabilities amounted to $9.8 million in Q3 2025, which was down 3771.58% from $8.8 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Total Current Liabilities high stood at $26.4 million for Q4 2023, and its period low was $2.1 million during Q1 2021.
- In the last 5 years, Whitehawk Therapeutics' Total Current Liabilities had a median value of $15.3 million in 2021 and averaged $14.5 million.
- As far as peak fluctuations go, Whitehawk Therapeutics' Total Current Liabilities soared by 47044.65% in 2022, and later crashed by 6046.42% in 2025.
- Whitehawk Therapeutics' Total Current Liabilities (Quarter) stood at $15.3 million in 2021, then increased by 23.32% to $18.8 million in 2022, then soared by 40.14% to $26.4 million in 2023, then crashed by 35.31% to $17.1 million in 2024, then tumbled by 42.32% to $9.8 million in 2025.
- Its last three reported values are $9.8 million in Q3 2025, $8.8 million for Q2 2025, and $12.3 million during Q1 2025.